ARCHIVES

Rituximab and Fludarabine Combination Produces Long-Term Remissions in CLL

This article is from The Cancer Letter archive.

Vol. 34 No. 3 | March 25, 2011

Download PDF Visit The Full Archive

Related Articles

FDA to refer false statements by regulated companies to SEC.

February 27, 2004

Phase 1 Study Asked to Determine If Drug Administration Timing Improves Results

April 4, 1986

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

President Proposes 2.1% Incerase for NIH, 2.4% Increase for NCI, In Year 2000 Budget

February 5, 1999

Overhead Caused By Outreach, Other Federal Programs Threatens Cancer Centers, Durant Contends

November 5, 1976

GAO Report Finds Increase in Self-Referred Pathology Services

August 9, 2013